Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Union Budget
Budget 2011-2012 Home
Industry Expectations - Budget 2011-2012
Industry Reactions - Budget 2011-2012
Budget 2010-2011
Budget 2010-2011 Home
Industry Expectations - Budget 2010-2011
Industry Reactions - Budget 2010-2011
Contributor's Corner
Bonanza Portfolio
Hemant K Gupta
Krish Bhatt
S A A R T H I
Trinity Investments
Exchange Information
BSE 2009 Holidays
NSE 2009 Holidays
Investor Guide
Depository & Dematerialisation
Grievance Redressal
Investor Guide
SEBI
Trading of Securities
Transfer of Securities
Your Rights
Budget 2009-2010
Budget 2009-2010 Home
Industry Expectations - Budget 2009-2010
Industry Reactions - Budget 2009-2010
Interim Budget 2009-2010 Home
Industry Expectations - Interim Budget 2009
Budget 2008-2009
Railway Budget 2008-2009
Industry Expectations - Budget 2008
Union Budget 2008-2009
Highlights of Budget 2008-2009
Summary of Budget 2008-2009
Industry Reactions - Budget 2008
IPOs
Current IPOs
Past IPOs
IPO Subscription
Mutual Funds
Gold Exchange Traded Fund
MF Unique Holding
Forthcoming Dividends
ELSS Schemes Comparison
Tax Plans
New Fund Offers
Research
Arbitrages
Equity
Market Whispers
Tax Planning
Home
Equity Linked Savings Scheme
Post Office MIS
9% GOI Senior Citizens Savings Scheme
8% Savings (Taxable) Bonds
Kisan Vikas Patra
National Savings Certificate
Public Provident Fund
Stock Report

| More

Hester Biosciences launches PPR vaccine and Goat Pox vaccine

Posted On: 2015-03-22 09:47:14

Hester Biosciences Limited, India's leading animal biological & health care company, launches its PPR (Peste Des Petits Ruminants) vaccine and Goat Pox vaccine. With the launch of these vaccines as well as being the second largest poultry vaccine manufacturer in India, Hester has positioned itself to capitalise on upcoming opportunities in the animal health care industry globally as well as in India.

PPR vaccine is to be given annually to sheep and goats. PPR disease causes dysentery and death of the animal. It is therefore a disease of high economical importance worldwide. The total targeted population of sheep and goat for PPR vaccine in the world is 145 crores. In India, the targeted population is 20 crores.

Mr. Rajiv Gandhi, CEO & MD, Hester Biosciences Ltd said "The world market for PPR vaccine is slated to be for INR 300 crores annually. The Indian market is slated to be INR 40 crores annually. The PPR vaccine will contribute toward also the disease eradication programs of the Government of India. Hester is also the first company in India to manufacture the Goat Pox vaccine. This vaccine is to be given annually to goats. Goat Pox disease causes death in Goats."

The total targeted population of goats for Goat Pox vaccine in the world is 97 crores, with 50% of that population being in Asia. In India, the targeted population is 14 crores. The world market for Goat Pox vaccine is slated to be for INR 500 crores annually. The Indian market is slated to be INR 70 crores annually.

Apart from poultry and large animal vaccines, the company has recently forayed into poultry health products and large animal health products. These four verticals put together will underpin Hester's identity as a strong animal health company, addressing all segments in the animal health care sector. Company currently manufactures and markets veterinary vaccines and health products for India and global markets. Company's product portfolio comprises of over 47 vaccines and over 35 health products.

"We have already invested INR 7 crores in plant and machinery for stepping up our vaccine production capacity as well as towards increasing our vaccine range. We hope to invest another INR 18 crore in the next couple of years. This expansion will help us to meet rising demand from domestic and export markets" said Mr. Gandhi.

"We at Hester aspire towards improving the health of animals by diagnosing & preventing diseases. Our R&D department is involved in the development of on new products and vaccines for preventing diseases. Company currently exports to eight countries and product registration activities are going on in over 20 countries. In the next 3-4 years international business would be equal or more than the domestic sales" added Mr. Gandhi.

The global animal healthcare market stands at around $ 22 billion, off which the market size in India is estimated to be $ 375 million. India has a huge poultry and cattle population and with growing awareness, market is expected to see a multi-fold increase in years to come.

Hester Biosciences is a company manufacturing animal vaccines and health products with a focus on R&D towards developing next generation recombinant vaccines. Located near the city of Ahmedabad, in the state of Gujarat, in Western India, Hester has a state-of-the-art manufacturing facility, having WHO-GMP, ISO 9001, ISO 14001, OHSAS 18001 & GLP certifications.

For the FY 2013-14, the company reported net profit of INR 10.09 crore on revenue of INR 69.05 crore. "Going forward we expect to cross INR 200 crore turnover by FY 16-17," said Mr. Gandhi. The company is listed on BSE and NSE.

Shares of HESTER BIOSCIENCES LTD. was last trading in BSE at Rs.473.7 as compared to the previous close of Rs. 485.2. The total number of shares traded during the day was 19565 in over 893 trades.

The stock hit an intraday high of Rs. 504 and intraday low of 455. The net turnover during the day was Rs. 9199487.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com





Other Headlines:

Navin Fluorine International Limited update on Dahej facility
The Thomas Cook India Group to acquire Kuoni's global network of Destination Management Specialists in 17 countries
Navin Fluorine International Limited Board approves Sub division / Stock Split
Shree Karthik Papers Ltd calls for Board Meeting on May 3, 2017
Navin Fluorine International Limited Board approves Dividend of Rs. 13
USFDA completes inspection of Strides Shasun Ltd's Oral Dosage Facility in Puducherry
Gillette India Ltd calls for Board Meeting on May 6, 2017
Procter & Gamble Hygiene and Healthcare Ltd calls for Board Meeting on May 5, 2017
Majestic Research Services and Solutions Ltd calls for Board Meting on 10th May, 2017
Cholamandalam Investment and Finance Company Ltd Board approves Dividend of Rs. 2
RPG Lifesciences Ltd recommends dividend of Rs. 2.80
Umang Dairies Ltd shuts down Gajraula plant temporarily
Chairman steps down from Board of DIC India Ltd
Dr. Reddy's Laboratories Ltd receives Form 483 with 11 observations for Bachupally Plant 3
Inter State Oil Carrier Ltd calls for Board Meeting On 29th May, 2017
Trigyn Awarded New York City FISA/OPA Information Technology & Consulting Contract
Gujarat Themis Biosyn Limited calls for Board Meeting on 10th May, 2017
Jubilant Industries Ltd announces resignation of CFO
Themis Medicare Limited calls for Board Meeting on May 10, 2017
Bharat Financial Inclusion Ltd clarifies on news regarding stake sale
Trident receives CII award
Vedanta Limited calls for Board Meeting On May 15, 2017
Deepak Nitrite recommends dividend of Rs. 1.20
Orient Cement Ltd calls for Board Meeting On May 5, 2017
Mangalore Chemicals & Fertilizers Ltd restarts plants
Siti Networks Ltd announces resignation of CFO
CARE reaffirms its ratings to Mahindra & Mahindra Limited
Kokuyo Camlin commissions new unit at Patalganga
Info Edge India Ltd clarifies on Media Report 'Zomato raises $20 million'
Thermax Bags Export Contracts Of USD 157 Million
Union Bank of India calls for Board Meeting on May 8, 2017
Punjab National Bank to raise Basel II compliant debt instrutment
Sangam Advisors Ltd calls for Board Meeting on Tuesday, May 09, 2017
Kesoram Industries annual operating profit rises to Rs. 135 crores
Sun Pharma Science Foundation recognizes Indian scientists & young research scholars
Diamines & Chemicals Ltd recommends dividend of Rs. 1.50
Orient Cement Ltd cancels Board Meeting on May 1, 2017
Suyog Telematics Ltd bags award
Oricon Enterprises Ltd's subsidiary enters into co-operation agreement with Pelliconi
NCLT approves merger of Hinduja Foundries Ltd with Ashok Leyland Ltd
IDFC Limited Board approves Dividend of Rs. 0.25
Lupin gets Form 483 with 3 observations for Goa facility
Shemaroo Entertainment Limited calls for Board Meeting on May 9, 2017
NIIT awarded as 'India's Most Trusted Training Brand' for the 5th consecutive year
CMI FPE Ltd calls for Board Meeting on May 30, 2017
Mangalam Drugs & Organics Ltd calls for Board Meeting on 8th May, 2017
Insilco Ltd shuts down unit at Gajraula
Lupin receives FDA approval for generic Benicar® Tablets
CEAT Ltd recommends dividend of Rs. 11.50
Aksharchem India Ltd calls for Board Meeting on May 27, 2017


Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2017